Advisory fee shares issued to B. Riley Securities
Company: Core Scientific
The claim, verbatim
386,697 shares of common stock were issued to B. Riley Securities, Inc. on August 1, 2022 as an advisory fee in connection with the bridge promissory notes
Source (primary)
Core Scientific 424B3 filed 2022-10-12 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “we have issued to BRS as an advisory fee in connection with our execution of two amended and restated bridge promissory notes on August 1, 2022”
How we checked this
Checked on September 22, 2026. The cited source supports part of this claim, but not all of it.
The document confirms the 386,697-share advisory-fee issuance to BRS tied to the notes, but the August 1, 2022 date describes the notes' execution, not the date the shares were issued.
Confirmed in the source:
- 386,697 shares of common stock were issued to B. Riley Securities, Inc. as an advisory fee
- The advisory fee was in connection with the execution of the bridge promissory notes
We could not confirm this from the cited source:
- That the 386,697 shares were issued to B. Riley Securities on August 1, 2022
That does not mean it is false — only that this source does not establish it, as of the date above. If we find a source that settles it, we will re-check and update this page.
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522260971/d409553d424b3.htm) in full (14,683 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-12
Quote: “we have issued to BRS as an advisory fee in connection with our execution of two amended and restated bridge promissory notes on August 1, 2022”